The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...

Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA ...

Tenpoint Therapeutics’ Yuvezzi brings a combination approach to presbyopia compared to single mechanisms of action offered by once-daily eye drops from Orasis Pharmaceuticals, Lenz Therapeutics, and ...

Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss ...

Tenpoint Therapeutics is set to join the US market for drugs to treat presbyopia, taking on rival therapies from AbbVie, ...

The FDA approved carbachol/brimonidine tartrate ophthalmic solution (Yuvezzi) for adults with presbyopia, marking the first ...

Tenpoint Therapeutics announced FDA’s approval of Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% ...

January 15, 2026 - PRESSADVANTAGE - Lucent Vision has published a new educational resource titled “What Practice Offers ...

Please provide your email address to receive an email when new articles are posted on . As presbyopia-correcting drops have started to enter the marketplace, many anterior segment surgeons are talking ...

Researchers estimate that about 1.8 billion people around the world live with presbyopia, a farsightedness condition that can appear as a person grows older. More recent treatment options for ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. When Bette Davis said, “Old age ain’t for sissies,” she ...

There are a range of techniques laser eye surgery, used to correct eyesight issues such as astigmatism, long and short-sightedness - Getty Click here to view this content. I’m one of 30 million people ...